Table 2 Age-specific vaccine-derived immunity used in the three vaccination scenarios we applied as additional susceptibility vectors when calculating the effective contact matrices
Age group | Scenario | ||
|---|---|---|---|
Vacc. 1 | Vacc. 2 | Vacc. 3 | |
0–4 | 0.0 | 0.0 | 0.0 |
5–10 | 0.0 | 0.0 | 0.0 |
11–17 | 0.0 | 0.0 | 0.0 |
18–29 | 0.1 | 0.1 | 0.8 |
30–39 | 0.1 | 0.1 | 0.8 |
40–49 | 0.1 | 0.5 | 0.8 |
50–59 | 0.1 | 0.8 | 0.8 |
60–69 | 0.5 | 0.8 | 0.8 |
70+ | 0.8 | 0.9 | 0.9 |